ATE483456T1 - Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel - Google Patents

Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel

Info

Publication number
ATE483456T1
ATE483456T1 AT07862155T AT07862155T ATE483456T1 AT E483456 T1 ATE483456 T1 AT E483456T1 AT 07862155 T AT07862155 T AT 07862155T AT 07862155 T AT07862155 T AT 07862155T AT E483456 T1 ATE483456 T1 AT E483456T1
Authority
AT
Austria
Prior art keywords
radiation
tumors
sensitizing agent
sensitization
radiation sensitization
Prior art date
Application number
AT07862155T
Other languages
English (en)
Inventor
James L Diebold
Robert L Hudkins
Sheila J Miknyoczki
Bruce Ruggeri
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39259576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE483456(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon Inc filed Critical Cephalon Inc
Application granted granted Critical
Publication of ATE483456T1 publication Critical patent/ATE483456T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07862155T 2006-11-20 2007-11-20 Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel ATE483456T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86003606P 2006-11-20 2006-11-20
PCT/US2007/024271 WO2008063644A1 (en) 2006-11-20 2007-11-20 Method of radio-sensitizing tumors using a radio-sensitizing agent

Publications (1)

Publication Number Publication Date
ATE483456T1 true ATE483456T1 (de) 2010-10-15

Family

ID=39259576

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07862155T ATE483456T1 (de) 2006-11-20 2007-11-20 Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel

Country Status (17)

Country Link
US (1) US20080146556A1 (de)
EP (1) EP2086525B1 (de)
JP (1) JP5542444B2 (de)
CN (1) CN101784268B (de)
AR (1) AR063869A1 (de)
AT (1) ATE483456T1 (de)
AU (1) AU2007321987B2 (de)
CA (1) CA2671517C (de)
CL (1) CL2007003331A1 (de)
DE (1) DE602007009717D1 (de)
ES (1) ES2352817T3 (de)
IL (1) IL198519A (de)
MX (1) MX2009005292A (de)
NZ (2) NZ595522A (de)
PT (1) PT2086525E (de)
TW (2) TWI519313B (de)
WO (1) WO2008063644A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY156873A (en) * 2009-08-26 2016-04-15 Cephalon Inc Novel forms of a multicyclic compound
TWI482621B (zh) 2009-12-23 2015-05-01 Sigma Tau Ind Farmaceuti 青蒿素基藥物與其他化學治療劑的抗癌組合物
TWI573792B (zh) 2012-02-01 2017-03-11 歐陸斯迪公司 新穎治療劑
US9771325B2 (en) 2014-02-14 2017-09-26 Council Of Scientific & Industrial Research Tricyclic compounds and preparation thereof
WO2015121876A1 (en) * 2014-02-14 2015-08-20 Council Of Scientific & Industrial Research Novel tricyclic compounds and preparation thereof
GB201409488D0 (en) 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
GB201409471D0 (en) 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
GB201409485D0 (en) 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
BR112017010588A2 (pt) * 2014-11-26 2018-05-15 Cephalon, Inc formas cristalinas de inibidores de parp
CN104961798A (zh) * 2015-06-28 2015-10-07 杨洋 作为parp抑制剂的化合物
AU2016426574B2 (en) 2016-10-11 2023-07-13 Euro-Celtique S.A. Hodgkin lymphoma therapy
GB201709406D0 (en) 2017-06-13 2017-07-26 Euro-Cletique S A Compounds for treating TNBC
GB201709403D0 (en) 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating sarcoma
GB201709405D0 (en) 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating ovarian cancer
GB201709402D0 (en) 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating t-pll
KR20210105380A (ko) 2018-12-18 2021-08-26 먼디파머 인터내셔널 코포레이션 리미티드 다발성 골수종을 치료하기 위한 화합물
CN113952452A (zh) * 2021-11-16 2022-01-21 苏州伊瑞斯科技有限公司 一种基于碳点的肿瘤放疗增敏剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635642B1 (en) * 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6197785B1 (en) * 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
CA2332279A1 (en) * 1998-05-15 1999-11-25 Jia-He Li Carboxamide compounds, compositions, and methods for inhibiting parp activity
US7122679B2 (en) * 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US20060276497A1 (en) * 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
AU2002331621B2 (en) * 2001-08-15 2008-06-05 Icos Corporation 2H-phthalazin-1-ones and methods for use thereof
MX2007003314A (es) * 2004-09-22 2007-08-06 Pfizer Combinaciones terapeuticas que comprenden inhibidor de poli(adp-ribosa)polimerasas.
US7728026B2 (en) * 2005-04-11 2010-06-01 Abbott Laboratories, Inc. 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors

Also Published As

Publication number Publication date
CA2671517C (en) 2015-01-27
JP5542444B2 (ja) 2014-07-09
CL2007003331A1 (es) 2008-07-04
ES2352817T3 (es) 2011-02-23
US20080146556A1 (en) 2008-06-19
CN101784268B (zh) 2013-06-19
DE602007009717D1 (de) 2010-11-18
TWI519313B (zh) 2016-02-01
CN101784268A (zh) 2010-07-21
IL198519A0 (en) 2010-02-17
CA2671517A1 (en) 2008-05-29
EP2086525A1 (de) 2009-08-12
AR063869A1 (es) 2009-02-25
NZ595522A (en) 2013-04-26
AU2007321987B2 (en) 2014-01-23
WO2008063644A1 (en) 2008-05-29
IL198519A (en) 2014-07-31
TW200829276A (en) 2008-07-16
HK1137347A1 (en) 2010-07-30
PT2086525E (pt) 2010-12-09
EP2086525B1 (de) 2010-10-06
TWI636795B (zh) 2018-10-01
MX2009005292A (es) 2009-08-13
TW201601762A (zh) 2016-01-16
JP2010510312A (ja) 2010-04-02
NZ576693A (en) 2011-12-22
AU2007321987A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
ATE483456T1 (de) Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel
ATE459416T1 (de) Verfahren zur beseitigung von endokrin wirksamen verbindungen
DE112007001421A5 (de) Mikroreaktoren-Array, Vorrichtung mit einem Mikroreaktoren-Array und Verfahren zur Verwendung eines Mikroreaktoren-Arrays
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
DE60315947D1 (de) Verfahren zur Sprachmodellierung
EP1973497A4 (de) Verfahren zur schnellen reparatur von körperleitungen
EP2217240A4 (de) Verfahren und verbindungen zur prävention und behandlung eines tumors
EP2032209A4 (de) Verfahren in einem medizinischen telemetriesystem
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
DE602007012538D1 (de) Verfahren und Vorrichtung zur Durchführung delegierter Transaktionen
EP2215257A4 (de) Verfahren zur diagnose von tumorerkrankungen
ATE474845T1 (de) Verfahren zur synthese von saccharose-6-estern
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
DE502005000127D1 (de) Verfahren zur Fahrtplanung eines Unterseebootes
DE602008006314D1 (de) Vorrichtung und Verfahren zur holographischen Datenspeicherung mit einer Phasenmaske
ATE523483T1 (de) Verfahren zur herstellung von betainen
EP2133158A4 (de) Verfahren zur entgiftung von asbest
DE602007003957D1 (de) Verfahren zur verbesserten spiralenschrift vor ort
ATE552250T1 (de) Verfahren zur herstellung von duloxetin und verwandten verbindungen
DE602006014011D1 (de) Verfahren zur Verringerung von Lichtinterferenzstreifen
ATE463162T1 (de) Verfahren zur verstärkung der wirksamkeit von ethaboxam
DE502005010287D1 (de) Verfahren zur hydrocyanierung
DE502007001211D1 (de) Verfahren zur Ermittlung von Objektparametern eines Fußgängers
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
DE112007001447A5 (de) Verfahren zur Abstandsregelung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties